FDA Approval Status Update for Sertraline Hydrochloride Supplement
The FDA has granted an Abbreviated New Drug Application (ANDA) approval status of 'AP' for Sertraline Hydrochloride submitted by Heritage Pharma Avet.
Company
Pharmaceutical intelligence for Heritage Pharma Avet with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.